Many new therapies are being developed to treat stroke and prevent its recurrence. While a number of these have been successfully introduced, there is a puzzling gap between evidence of efficacy in animal models and humans. One of the main reasons may be lack of an integrated approach between the basic sciences and clinical researchers. By assembling a team with skills in both areas and a structure to maximise communication between groups this team plan to incrementally introduce new therapies i ....Many new therapies are being developed to treat stroke and prevent its recurrence. While a number of these have been successfully introduced, there is a puzzling gap between evidence of efficacy in animal models and humans. One of the main reasons may be lack of an integrated approach between the basic sciences and clinical researchers. By assembling a team with skills in both areas and a structure to maximise communication between groups this team plan to incrementally introduce new therapies into clinical practice.Read moreRead less
I am a neuroscientist employing strategies of anatomy, biochemistry, pharmacology, genetics and behavioural analysis to examine the physiological and possible pathological roles of newly discovered neuropeptides and their cognate receptors in mammalian brain. My recent research has focused on the highly-conserved, abundant peptide, relaxin-3 that was discovered at the HFI in 2002. Studies so far have revealed that relaxin-3 is a powerful modulator of rhythmic brain activity (theta) and spatial m ....I am a neuroscientist employing strategies of anatomy, biochemistry, pharmacology, genetics and behavioural analysis to examine the physiological and possible pathological roles of newly discovered neuropeptides and their cognate receptors in mammalian brain. My recent research has focused on the highly-conserved, abundant peptide, relaxin-3 that was discovered at the HFI in 2002. Studies so far have revealed that relaxin-3 is a powerful modulator of rhythmic brain activity (theta) and spatial memory, and alters feeding, body weight and arousal. Relaxin-3 levels in brain are also strongly activated by acute stress. In the future, I aim to elucidate further the role of relaxin-3 systems in normal physiology and metabolic and-or psychiatric diseases.Read moreRead less